Standardizing Data Collection to Support Clinicians in the Opioid Fight

By David Bucciferro and Katelyn Fontaine
EHRA Opioid Crisis Task Force

EHRA recommended minimum data set for PDMP inquiry
Click here to view full recommended ideal minimum data set.

Volunteers on EHRA’s Opioid Crisis Task Force have made great strides in the past year in our efforts to identify the policy changes and adoption patterns needed to maximize the capacities of health IT to combat the opioid crisis.

From the start, our focus has been, What do providers need from technology to support their efforts in the opioid crisis?

When we began our work in early 2018, we were surprised to find that there was no comprehensive source for the state-specific policies and standards surrounding prescription drug monitoring programs (PDMPs) and electronic prescribing of controlled substances (EPCS). So, we set out to create our own.    

(more…)

IPPS: Ambiguous Measures Won’t Reduce Burden

By Sasha TerMaat
Co-Chair, EHRA Executive Committee

man holding three white medication pills

The final 2019 IPPS rule included changes to the Promoting Interoperability/ Meaningful Use program beginning January 1, 2019. Disappointingly, with only six weeks between the close of the public comment period for the proposed rule in late June and the publication of the final rule in early August, CMS’ rushed process and failure to fully consider stakeholder comments (including EHRA’s) led to a rule filled with measures that will be unworkable, inefficient, and onerous.

In a previous blog we delved into PDMP query as just one of the measures where EHR developers anticipate challenges. In that case it’s due to differing levels of PDMP integration with CEHRT and inconsistent references within the rule about whether the query needs to be made via CEHRT, along with other areas in which the measure is ambiguous.  

In this blog post, let’s look at the reasons we’re concerned about a different measure, this one related to opioid treatment agreements.

(more…)

Why HHS Needs a Privacy Leader and a Cybersecurity Leader

By Nam Nguyen and Sayee Balaji Chandrasekaran, Chair and Vice Chair, EHRA Privacy & Security Workgroup

_Security and Privacy are not the same. A Security leader_s primary concern is protecting and securing data. A Privacy leader_s primary concern is who can access certain data and whaCyber-threats are all over the news, including attempts to hack elections, steal corporate trade secrets, and hold medical records for ransom. Phishing is rampant, and is the way most hackers ultimately get into secure systems. The U.S. government has, of course, taken notice, and is taking action on several fronts.

One of those fronts is healthcare, with the release by HHS of the Health Care Industry Cybersecurity Task Force’s “Report on Improving Cybersecurity in the Health Care Industry,” which was delivered to Congress in June 2017.  The task force wrote, “Our nation must find a way to prevent our patients from being forced to choose between connectivity and security.”

EHRA welcomes this report, which we view as a path forward for increasing security in the healthcare sector.  The report directly aligns with two of EHRA’s privacy and security positions: (more…)

Draft TEFCA Needs A Lot More Work

TEFCASince the release of the Draft Trusted Exchange Framework and Common Agreement (TEFCA) on January 5th, EHRA volunteers from the Standards and Interoperability, Privacy and Security, and Public Policy Leadership Workgroups have been reviewing and discussing the document. Together, they drafted EHRA’s comments, which were submitted this week to the Office of the National Coordinator for Health IT (ONC).

As EHR developers, we support the goal to provide nationwide interoperability using networks as important building blocks, and believe TEFCA has the potential to dramatically improve interoperability.

However, the draft TEFCA overreaches, neglects important details, and doesn’t consider the practicality or potential unintended consequences of the policy. We strongly recommend that ONC review stakeholder feedback and publish a revised proposed draft for another round of feedback, before finalizing the policy.

(more…)

Reflections on EHRA, Past and Future

By Mark Segal, PhD, FHIMSS

Mark Segal Morocco

Mark Segal welcomed ‘retirement’ by exploring Morocco with his son.

Late in 2017, I left GE Healthcare via an early “retirement” opportunity. Retirement is in quotes but that is a story for another day; suffice it to say that I intend to remain active in the digital health policy world.

One of the biggest changes with my departure from GE is that I also left the EHRA Executive Committee, on which I had served in both elected and ex officio capacity for years. This was a double whammy of many fewer conference calls per day.

My involvement with EHRA, wearing many hats, has been one of the most important and satisfying aspects of my professional life. (more…)

FDA Health IT Guidance Is A Good Start, But More Clarity Is Needed

By Shari Medina, MD

This month, the FDA issued long-awaited guidelines EHR tablet graphicon the agency’s implementation of the 21st Century Cures Act in regards to Clinical Decision Support and the FDA’s intent to exercise enforcement discretion for many types of patient-facing software, mobile applications, and software which have not obtained ONC certification.
(more…)